Compare UBC Medical Indonesia Tbk. (LABS) vs Satu Visi Putra Tbk. (VISI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UBC Medical Indonesia Tbk. vs Satu Visi Putra Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume), while Satu Visi Putra Tbk. trades at Rp925 (market cap 2.94T, 977.1K 24h volume). The key difference: Satu Visi Putra Tbk. is far larger — about 4.6× UBC Medical Indonesia Tbk.'s market cap, and Satu Visi Putra Tbk. is more actively traded (977.1K versus 843K). Which is the better fit depends on your goals.
| LABS | VISI | |
|---|---|---|
Market Cap | 635.95B | 2.94T |
Volume | 843K | 977.1K |
Lot | 8.43K | 9.77K |
Turnover | 137.6M | 914.21M |
Average Price | 163.22 | 935.64 |
Value | 137.6M | 914.21M |
Indicative Equilibrium Price | 165 | 925 |
Indicative Equilibrium Volume | 246 | 360 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →About Satu Visi Putra Tbk.
PT Satu Visi Putra Tbk (the Entity) was established based on Deed No. 16, dated February 14, 2018 of Soeprayitno, S.H., notary in Surabaya. The Entity started its commercial operation in 2018.
Read more on VISI →
